Our results seem to be consistent with this hypothesis regarding the elevated ICAM-1 levels in class III obesity group, while no statistically significant change in initial stages of obesity (obesity class I and II). The gene discussed is ICAM1; the disease is obesity due to melanocortin 4 receptor deficiency.